/DCGO
DCGO Stock - DocGo Inc.
Healthcare|Medical - Care FacilitiesNASDAQ
$0.87-2.94%
$0.03 (-2.94%) • Jan 13
61
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.82
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+72.2%upside
Target: $1.50
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for DCGO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.86 – $0.88
TARGET (TP)$1.50
STOP LOSS$0.80
RISK/REWARD1:8.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.94
52W High$5.67
52W Low$0.85
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $616.56M | $624.29M | $440.52M | $318.72M | $94.09M |
| Gross Profit | $213.57M | $195.38M | $154.72M | $109.75M | $31.35M |
| Gross Margin | 34.6% | 31.3% | 35.1% | 34.4% | 33.3% |
| Operating Income | $28.69M | $15.05M | $21.83M | $15.36M | $-14,757,683 |
| Net Income | $19.99M | $6.86M | $34.58M | $23.74M | $-14,359,944 |
| Net Margin | 3.2% | 1.1% | 7.9% | 7.4% | -15.3% |
| EPS | $0.20 | $0.07 | $0.34 | $0.30 | $-0.14 |
Company Overview
DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
2
50%
Hold / Neutral
2
50%
Sell / Underperform
0%
Analyst Consensus🟡 Mixed
2 Bullish2 Neutral/Bearish
Price Targets
$10
Average Target
↑ 1043.8% Upside
Now
$3
Low
$10
Average
$15
High
Based on 4 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| May 9th 2025 | BTIG Research | Downgrade | Neutral | - |
| February 28th 2025 | Deutsche Bank | Downgrade | Hold | $2.85← $5 |
| August 18th 2023 | BTIG Research | Initiation | Buy | $15 |
| April 21st 2023 | Cantor Fitzgerald | Initiation | Overweight | $11 |
| April 19th 2022 | Deutsche Bank | Initiation | Buy | $11 |
Earnings History & Surprises
DCGOBeat Rate
31%
Last 16 quarters
Avg Surprise
+5.3%
EPS vs Estimate
Beats / Misses
5/9
2 met exactly
Latest EPS
$-0.11
Q4 2025
EPS Surprise History
Q1 24
-30.0%
$0.07vs$0.10
Q2 24
+25.0%
$0.10vs$0.08
Q3 24
-12.5%
$0.07vs$0.08
Q4 24
0.0%
$0.05vs$0.05
Q1 25
-20.0%
$0.04vs$0.05
Q2 25
-800.0%
$-0.09vs$-0.01
Q3 25
-83.3%
$-0.11vs$-0.06
Q4 25
-22.2%
$-0.11vs$-0.09
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | $-0.09 | — | — | — |
Q4 2025 | Nov 10, 2025 | $-0.09 | $-0.11 | -22.2% | ✗ MISS |
Q3 2025 | Aug 7, 2025 | $-0.06 | $-0.11 | -83.3% | ✗ MISS |
Q2 2025 | May 8, 2025 | $-0.01 | $-0.09 | -800.0% | ✗ MISS |
Q1 2025 | Feb 27, 2025 | $0.05 | $0.04 | -20.0% | ✗ MISS |
Q4 2024 | Nov 7, 2024 | $0.05 | $0.05 | 0.0% | = MET |
Q3 2024 | Aug 7, 2024 | $0.08 | $0.07 | -12.5% | ✗ MISS |
Q2 2024 | May 8, 2024 | $0.08 | $0.10 | +25.0% | ✓ BEAT |
Q1 2024 | Feb 28, 2024 | $0.10 | $0.07 | -30.0% | ✗ MISS |
Q4 2023 | Nov 6, 2023 | $0.06 | $0.05 | -16.7% | ✗ MISS |
Q3 2023 | Aug 7, 2023 | $-0.01 | $-0.02 | -166.7% | ✗ MISS |
Q2 2023 | May 8, 2023 | $-0.01 | $-0.03 | -238.6% | ✗ MISS |
Q1 2023 | Mar 13, 2023 | $0.05 | $0.11 | +120.0% | ✓ BEAT |
Q4 2022 | Nov 7, 2022 | $0.05 | $0.05 | 0.0% | = MET |
Q3 2022 | Aug 8, 2022 | $0.02 | $0.07 | +199.9% | ✓ BEAT |
Q2 2022 | May 9, 2022 | $0.05 | $0.09 | +80.0% | ✓ BEAT |
Q1 2022 | Mar 14, 2022 | $0.01 | $0.17 | +1050.2% | ✓ BEAT |
Q4 2021 | Nov 15, 2021 | — | $0.04 | — | — |
Q3 2021 | Aug 11, 2021 | — | $-0.02 | — | — |
Latest News
CORRECTION: DocGo Q3 Adj. EPS $(0.11) Beats $(0.12) Estimate, Sales $70.810M Beat $69.770M Estimate
📈 PositiveBenzinga•Nov 10, 2025, 11:22 PM
DocGo shares are trading lower after the company reported mixed Q3 financial results and narrowed its FY25 sales guidance.
📉 NegativeBenzinga•Nov 10, 2025, 09:27 PM
DocGo Narrows FY2025 Sales Guidance from $300.000M-$330.000M to $315.000M-$320.000M vs $317.559M Est
➖ NeutralBenzinga•Nov 10, 2025, 09:06 PM
DocGo Q3 EPS $(0.28) Misses $(0.12) Estimate, Sales $70.810M Beat $69.770M Estimate
➖ NeutralBenzinga•Nov 10, 2025, 09:06 PM
DocGo Plans To Roll Out Longitudinal Care Services In Q4 In Collaboration With California-Based Insurance Provider
📈 PositiveBenzinga•Nov 4, 2025, 12:38 PM
DocGo shares are trading higher after the company acquired virtual care platform SteadyMD, which is expected to generate about $25 million in 2025 revenue and be EBITDA positive in 2026.
📈 PositiveBenzinga•Oct 21, 2025, 11:15 AM
DocGo stock surges on deal to acquire virtual care platform SteadyMD
📈 PositiveSeeking Alpha•Oct 21, 2025, 09:12 AM
DocGo Acquires Virtual Care Platform SteadyMD; No Financial Terms Disclosed; In 2025, SteadyMD Is Expected To Generate ~$25M In Revenue And Is Expected To Be EBITDA Positive For 2026
📈 PositiveBenzinga•Oct 20, 2025, 09:23 PM
Canaccord Genuity Maintains Hold on DocGo, Raises Price Target to $1.6
➖ NeutralBenzinga•Aug 21, 2025, 03:41 PM•Also:
Frequently Asked Questions about DCGO
What is DCGO's current stock price?
DocGo Inc. (DCGO) is currently trading at $0.87 per share. The stock has moved -2.94% today.
What is the analyst price target for DCGO?
The average analyst price target for DCGO is $1.50, based on 1 analyst.
What sector is DocGo Inc. in?
DocGo Inc. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the NASDAQ exchange.
What is DCGO's market cap?
DocGo Inc. has a market capitalization of $0.09 billion, making it a small-cap company.
Does DCGO pay dividends?
No, DocGo Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCOYA
Coya Therapeutics, Inc.
$4.48
Mkt Cap: $0.1B
IMMX
Immix Biopharma, Inc.
$4.41
Mkt Cap: $0.1B
MBOT
Microbot Medical Inc.
$2.15
Mkt Cap: $0.1B
MGNX
MacroGenics, Inc.
$1.81
Mkt Cap: $0.1B
NSPR
InspireMD, Inc.
$1.61
Mkt Cap: $0.1B
OVID
Ovid Therapeutics Inc.
$1.64
Mkt Cap: $0.1B
PRLD
Prelude Therapeutics Incorporated
$2.22
Mkt Cap: $0.2B
QIPT
Quipt Home Medical Corp.
$3.60
Mkt Cap: $0.2B
RCEL
AVITA Medical, Inc.
$3.32
Mkt Cap: $0.1B
VANI
Vivani Medical, Inc.
$1.29
Mkt Cap: $0.1B
Explore stocks similar to DCGO for comparison